The Bacteroides fragilis cell envelope: Quarterback, linebacker, coach-or all three?

Anaerobe

Volumn 12, Issue 5-6, 2006, Pages 211-220

  Pumbwe, Lilian ^a   Skilbeck, Christopher A ^a   Wexler, Hannah M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL ENZYME; BACTERIAL TOXIN; BETA LACTAM; BETA LACTAMASE; BROMIDE; CARBAPENEM DERIVATIVE; CEFOXITIN; CIPROFLOXACIN; DNA; ETHIDIUM; LEVOFLOXACIN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; METRONIDAZOLE; MOXIFLOXACIN; NORFLOXACIN; PERIODATE; POLYSACCHARIDE; SIALIDASE; TETRACYCLINE; TRICLOSAN; TRYPSIN;

ANAEROBIC INFECTION; ANTIBIOTIC RESISTANCE; ANTIGENICITY; ANTIMICROBIAL THERAPY; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIUM ADHERENCE; BACTERIUM PILUS; BACTEROIDES FRAGILIS; BILE; ECOLOGICAL NICHE; FIMBRIA; GLYCOCALYX; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; SHORT SURVEY; TISSUE INJURY;

BACTERIAL CAPSULES; BACTERIAL OUTER MEMBRANE PROTEINS; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; BILE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FIMBRIAE, BACTERIAL; HUMANS; INTESTINES;

BACTERIA (MICROORGANISMS); BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON;

EID: 33750532744     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2006.09.004     Document Type: Short Survey

References (99)

1. Willis A.T. Abdominal sepsis. In: Duerden B.I., and Drasar B.S. (Eds). Anaerobes in human disease (1991), Wiley-Liss, New York 197-223
2. Oyston P.C., and Handley P.S. Surface components of Bacteroides fragilis involved in adhesion and haemagglutination. J Med Microbiol 34 (1991) 51-55
3. Ferreira R., Alexandre M.C., Antunes E.N., Pinhao A.T., Moraes S.R., Ferreira M.C., et al. Expression of Bacteroides fragilis virulence markers in vitro. J Med Microbiol 48 (1999) 999-1004
4. Pruzzo C., Dainelli B., and Ricchetti M. Piliated Bacteroides fragilis strains adhere to epithelial cells and are more sensitive to phagocytosis by human neutrophils than nonpiliated strains. Infect Immun 43 (1984) 189-194
5. Oyston P.C., and Handley P.S. Surface structures, haemagglutination and cell surface hydrophobicity of Bacteroides fragilis strains. J Gen Microbiol 136 (1990) 941-948
6. Brook I., and Myhal M.L. Adherence of Bacteroides fragilis group species. Infect Immun 59 (1991) 742-744
7. Babu M.M., Priya M.L., Selvan A.T., Madera M., Gough J., Aravind L., et al. A database of bacterial lipoproteins (DOLOP) with functional assignments to predicted lipoproteins. J Bacteriol 188 (2006) 2761-2773
8. Bendtsen J.D., Binnewies T.T., Hallin P.F., Sicheritz-Ponten T., and Ussery D.W. Genome update: prediction of secreted proteins in 225 bacterial proteomes. Microbiology 151 (2005) 1725-1727
9. Rogemond V., and Guinet R.M. Lectinlike adhesins in the Bacteroides fragilis group. Infect Immun 53 (1986) 99-102
10. Domingues R.M., Cavalcanti S.M., Andrade A.F., and Ferreira M.C. Sialic acid as receptor of Bacteroides fragilis lectin-like adhesin. Zentralbl Bakteriol 277 (1992) 340-344
11. Guzman C.A., Plate M., and Pruzzo C. Role of neuraminidase-dependent adherence in Bacteroides fragilis attachment to human epithelial cells. FEMS Microbiol Lett 59 (1990) 187-192
12. Namavar F., Van der Bijl M.W., Appelmelk B.J., de G.J., and Maclaren D.M. The role of neuraminidase in haemagglutination and adherence to colon WiDr cells by Bacteroides fragilis. J Med Microbiol 40 (1994) 393-396
13. Sjogren A., Hovmoller S., Farrants G., Ranta H., Haapasalo M., Ranta K., et al. Structures of two different surface layers found in six Bacteroides strains. J Bacteriol 164 (1985) 1278-1282
14. Haapasalo M. Bacteroides buccae and related taxa in necrotic root canal infections. J Clin Microbiol 24 (1986) 940-944
15. Yoneda M., Hirofuji T., Motooka N., Nozoe K., Shigenaga K., Anan H., et al. Humoral immune responses to S-layer-like proteins of Bacteroides forsythus. Clin Diagn Lab Immunol 10 (2003) 383-387
16. Sabet M., Lee S.W., Nauman R.K., Sims T., and Um H.S. The surface (S-) layer is a virulence factor of Bacteroides forsythus. Microbiology 149 (2003) 3617-3627
17. Xu J., Bjursell M.K., Himrod J., Deng S., Carmichael L.K., Chiang H.C., et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299 (2003) 2074-2076
18. Pantosti A., Tzianabos A.O., Onderdonk A.B., and Kasper D.L. Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect Immun 59 (1991) 2075-2082
19. Tzianabos A.O., Pantosti A., Baumann H., Brisson J.R., Jennings H.J., and Kasper D.L. The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J Biol Chem 267 (1992) 18230-18235
20. Baumann H., Tzianabos A.O., Brisson J.R., Kasper D.L., and Jennings H.J. Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy. Biochemistry 31 (1992) 4081-4089
21. Wang Y., Kalka-Moll W.M., Roehrl M.H., and Kasper D.L. Structural basis of the abscess-modulating polysaccharide A2 from Bacteroides fragilis. Proc Natl Acad Sci USA 97 (2000) 13478-13483
22. Pantosti A., Tzianabos A.O., Reinap B.G., Onderdonk A.B., and Kasper D.L. Bacteroides fragilis strains express multiple capsular polysaccharides. J Clin Microbiol 31 (1993) 1850-1855
23. Kalka-Moll W.M., Wang Y., Comstock L.E., Gonzalez S.E., Tzianabos A.O., and Kasper D.L. Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain. Infect Immun 69 (2001) 2339-2344
24. Coyne M.J., Kalka-Moll W., Tzianabos A.O., Kasper D.L., and Comstock L.E. Bacteroides fragilis NCTC9343 produces at least three distinct capsular polysaccharides: cloning, characterization, and reassignment of polysaccharide B and C biosynthesis loci. Infect Immun 68 (2000) 6176-6181
25. Tzianabos A.O., Onderdonk A.B., Rosner B., Cisneros R.L., and Kasper D.L. Structural features of polysaccharides that induce intra-abdominal abscesses. Science 262 (1993) 416-419
26. Tzianabos A.O., Kasper D.L., and Onderdonk A.B. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses. Clin Infect Dis 20 Suppl 2 (1995) S132-S140
27. Reid J.H., and Patrick S. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis. J Med Microbiol 17 (1984) 247-257
28. Simon G.L., Klempner M.S., Kasper D.L., and Gorbach S.L. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide. J Infect Dis 145 (1982) 72-77
29. Gemmell C.G., Peterson P.K., Schmeling D., Mathews J., and Quie P.G. Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes. Eur J Clin Microbiol 2 (1983) 327-334
30. Beena V.K., and Shivananda P.G. In vitro adhesiveness of Bacteroides fragilis group in relation to encapsulation. Indian J Med Res 105 (1997) 258-261
31. Brook I., Coolbaugh J.C., and Walker R.I. Pathogenicity of piliated and encapsulated Bacteroides fragilis. Eur J Clin Microbiol 3 (1984) 207-209
32. Patrick S., Gilpin D., and Stevenson L. Detection of intrastrain antigenic variation of Bacteroides fragilis surface polysaccharides by monoclonal antibody labelling. Infect Immun 67 (1999) 4346-4351
33. Korenevsky A.A., Vinogradov E., Gorby Y., and Beveridge T.J. Characterization of the lipopolysaccharides and capsules of Shewanella spp. Appl Environ Microbiol 68 (2002) 4653-4657
34. Weintraub A., Larsson B.E., and Lindberg A.A. Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides. Infect Immun 49 (1985) 197-201
35. Delahooke D.M., Barclay G.R., and Poxton I.R. A re-appraisal of the biological activity of bacteroides LPS. J Med Microbiol 42 (1995) 102-112
36. Patrick S., McKenna J.P., O'Hagan S., and Dermott E. A comparison of the haemagglutinating and enzymic activities of Bacteroides fragilis whole cells and outer membrane vesicles. Microb Pathog 20 (1996) 191-202
37. Domingues R.M., Silva e Souza, Moraes S.R., Avelar K.E., Hirata J.R., Fonseca M.E., et al. Surface vesicles: a possible function in commensal relations of Bacteroides fragilis. Zentralbl Bakteriol 285 (1997) 509-517
38. Dutson T.R., Pearson A.M., Price J.F., Spink G.C., and Tarrant P.J. Observations by electron microscopy on pig muscle inoculated and incubated with Pseudomonas fragi. Appl Microbiol 22 (1971) 1152-1158
39. Grenier D., and Mayrand D. Functional characterization of extracellular vesicles produced by Bacteroides gingivalis. Infect Immun 55 (1987) 111-117
40. Khandelwal P., Choudhury D., Birah A., Reddy M.K., Gupta G.P., and Banerjee N. Insecticidal pilin subunit from the insect pathogen Xenorhabdus nematophila. J Bacteriol 186 (2004) 6465-6476
41. Mashburn L.M., and Whiteley M. Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature 437 (2005) 422-425
42. Wang R.C., Seror S.J., Blight M., Pratt J.M., Broome-Smith J.K., and Holland I.B. Analysis of the membrane organization of an Escherichia coli protein translocator, HlyB, a member of a large family of prokaryote and eukaryote surface transport proteins. J Mol Biol 217 (1991) 441-454
43. Cerdeno-Tarraga A.M., Patrick S., Crossman L.C., Blakely G., Abratt V., Lennard N., et al. Extensive DNA inversions in the B. fragilis genome control variable gene expression: supplemental online material. Science 307 (2005) 1463-1465
44. Sears C.L. The toxins of Bacteroides fragilis. Toxicon 39 (2001) 1737-1746
45. Wu S., Lim K.C., Huang J., Saidi R.F., and Sears C.L. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci USA 95 (1998) 14979-14984
46. Obiso Jr. R.J., Azghani A.O., and Wilkins T.D. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect Immun 65 (1997) 1431-1439
47. Wu S., Shin J., Zhang G., Cohen M., Franco A., and Sears C.L. The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Infect Immun 74 (2006) 5382-5390
48. Kim J.M., Lee J.Y., Yoon Y.M., Oh Y.K., Kang J.S., Kim Y.J., et al. Bacteroides fragilis enterotoxin induces cyclooxygenase-2 and fluid secretion in intestinal epithelial cells through NF-kappaB activation. Eur J Immunol 36 (2006) 2446-2456
49. Toprak N.U., Yagci A., Gulluoglu B.M., Akin M.L., Demirkalem P., Celenk T., et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 12 (2006) 782-786
50. Gibson S.A., and Macfarlane G.T. Characterization of proteases formed by Bacteroides fragilis. J Gen Microbiol 134 (1988) 2231-2240
51. Rudek W., and Haque R.U. Extracellular enzymes of the genus Bacteroides. J Clin Microbiol 4 (1976) 458-460
52. Chen Y., Kinouchi T., Kataoka K., Akimoto S., and Ohnishi Y. Purification and characterization of a fibrinogen-degrading protease in Bacteroides fragilis strain YCH46. Microbiol Immunol 39 (1995) 967-977
53. Macfarlane G.T., Macfarlane S., and Gibson G.R. Synthesis and release of proteases by Bacteroides fragilis. Curr Microbiol 24 (1992) 55-59
54. Berg J.O., Lindqvist L., Andersson G., and Nord C.E. Neuraminidase in Bacteroides fragilis. Appl Environ Microbiol 46 (1983) 75-80
55. Tanaka H., Ito F., and Iwasaki T. Purification and characterization of a sialidase from Bacteroides fragilis SBT3182. Biochem Biophys Res Commun 189 (1992) 524-529
56. Godoy V.G., Dallas M.M., Russo T.A., and Malamy M.H. A role for Bacteroides fragilis neuraminidase in bacterial growth in two model systems. Infect Immun 61 (1993) 4415-4426
57. Avelar K.E., Pinto L.J., Antunes L.C., Lobo L.A., Bastos M.C., Domingues R.M., et al. Production of bacteriocin by Bacteriodes fragilis and partial characterization. Lett Appl Microbiol 29 (1999) 264-268
58. Mossie K.G., Robb F.T., Jones D.T., and Woods D.R. Inhibition of ribonucleic acid polymerase by a bacteriocin from Bacteroides fragilis. Antimicrob Agents Chemother 20 (1981) 437-442
59. Wexler H.M., Read E.K., and Tomzynski T.J. Identification of an OmpA protein from Bacteroides fragilis: ompA gene sequence, OmpA amino acid sequence and predictions of protein structure. Anaerobe 8 (2002) 180-191
60. Weiser J.N., and Gotschlich E.C. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun 59 (1991) 2252-2258
61. Otto B.R., Sparrius M., Verweij-van Vught A.M., and Maclaren D.M. Iron-regulated outer membrane protein of Bacteroides fragilis involved in heme uptake. Infect Immun 58 (1990) 3954-3958
62. Tancula E., Feldhaus M.J., Bedzyk L.A., and Salyers A.A. Location and characterization of genes involved in binding of starch to the surface of Bacteroides thetaiotaomicron. J Bacteriol 174 (1992) 5609-5616
63. Shipman J.A., Berleman J.E., and Salyers A.A. Characterization of four outer membrane proteins involved in binding starch to the cell surface of Bacteroides thetaiotaomicron. J Bacteriol 182 (2000) 5365-5372
64. Shipman J.A., Cho K.H., Siegel H.A., and Salyers A.A. Physiological characterization of SusG, an outer membrane protein essential for starch utilization by Bacteroides thetaiotaomicron. J Bacteriol 181 (1999) 7206-7211
65. Salyers A.A., and Pajeau M. Competitiveness of different polysaccharide utilization mutants of Bacteroides thetaiotaomicron in the intestinal tracts of germfree mice. Appl Environ Microbiol 55 (1989) 2572-2578
66. Reeves A.R., D'Elia J.N., Frias J., and Salyers A.A. A Bacteroides thetaiotaomicron outer membrane protein that is essential for utilization of maltooligosaccharides and starch. J Bacteriol 178 (1996) 823-830
67. Reeves A.R., Wang G.R., and Salyers A.A. Characterization of four outer membrane proteins that play a role in utilization of starch by Bacteroides thetaiotaomicron. J Bacteriol 179 (1997) 643-649
68. McCarthy R.E., Pajeau M., and Salyers A.A. Role of starch as a substrate for Bacteroides vulgatus growing in the human colon. Appl Environ Microbiol 54 (1988) 1911-1916
69. D'Elia J.N., and Salyers A.A. Effect of regulatory protein levels on utilization of starch by Bacteroides thetaiotaomicron. J Bacteriol 178 (1996) 7180-7186
70. D'Elia J.N., and Salyers A.A. Contribution of a neopullulanase, a pullulanase, and an alpha-glucosidase to growth of Bacteroides thetaiotaomicron on starch. J Bacteriol 178 (1996) 7173-7179
71. Cho K.H., and Salyers A.A. Biochemical analysis of interactions between outer membrane proteins that contribute to starch utilization by Bacteroides thetaiotaomicron. J Bacteriol 183 (2001) 7224-7230
72. Cho K.H., Cho D., Wang G.R., and Salyers A.A. New regulatory gene that contributes to control of Bacteroides thetaiotaomicron starch utilization genes. J Bacteriol 183 (2001) 7198-7205
73. Anderson K.L., and Salyers A.A. Genetic evidence that outer membrane binding of starch is required for starch utilization by Bacteroides thetaiotaomicron. J Bacteriol 171 (1989) 3199-3204
74. Anderson K.L., and Salyers A.A. Biochemical evidence that starch breakdown by Bacteroides thetaiotaomicron involves outer membrane starch-binding sites and periplasmic starch-degrading enzymes. J Bacteriol 171 (1989) 3192-3198
75. Hooper L.V., Midtvedt T., and Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22 (2002) 283-307
76. Park J.T. Identification of a dedicated recycling pathway for anhydro-N-acetylmuramic acid and N-acetylglucosamine derived from Escherichia coli cell wall murein. J Bacteriol 183 (2001) 3842-3847
77. Xu J., and Gordon J.I. Inaugural article: honor thy symbionts. Proc Natl Acad Sci USA 100 (2003) 10452-10459
78. Xu J., Bjursell M.K., Himrod J., Deng S., Carmichael L.K., Chiang H.C., et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299 (2003) 2074-2076
79. Sonnenburg J.L., Angenent L.T., and Gordon J.I. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine?. Nat Immunol 5 (2004) 569-573
80. Wexler H.M., Read E.K., and Tomzynski T.J. Characterization of omp200, a porin gene complex from Bacteroides fragilis: omp121 and omp71, gene sequence, deduced amino acid sequence and predictions of porin structure. Gene 283 (2002) 95-105
81. Ueda O., Wexler H.M., Hirai K., Shibata Y., Yoshimura F., and Fujimura S. Sixteen homologs of the mex-type multidrug resistance efflux pump in Bacteroides fragilis. Antimicrob Agents Chemother 49 (2005) 2807-2815
82. Pumbwe L., Ueda O., Yoshimura F., Chang A., Smith R., and Wexler H.M. Bacteroides fragilis BmeABC efflux systems additively confer intrinsic antimicrobial resistance. J Antimicrob Chemother 58 (2006) 37-46
83. Lin J., Cagliero C., Guo B., Barton Y.W., Maurel M.C., Payot S., et al. Bile salts modulate expression of the CmeABC multidrug efflux pump in Campylobacter jejuni. J Bacteriol 187 (2005) 7417-7424
84. Buckley A.M., Webber M.A., Cooles S., Randall L.P., La Ragione R.M., Woodward M.J., et al. The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell Microbiol 8 (2006) 847-856
85. Piddock L.J. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19 (2006) 382-402
86. Piddock L.J. Multidrug-resistance efflux pumps-not just for resistance. Nat Rev Microbiol 4 (2006) 629-636
87. Pumbwe L, Wareham DW, Aduse-Opoku J, Brazier JS, Wexler HM. Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis. Clinical Microbiology and Infections 2006, in press.
88. Pumbwe L., Glass D., and Wexler H.M. Efflux pump overexpression in multiple antibiotic resistant mutants of Bacteroides fragilis. Antimicrob Agents Chemother 50 (2006) 3150-3153
89. Macfarlane S., Woodmansey E.J., and Macfarlane G.T. Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl Environ Microbiol 71 (2005) 7483-7492
90. Cerdeno-Tarraga A.M., Patrick S., Crossman L.C., Blakely G., Abratt V., Lennard N., et al. Extensive DNA inversions in the B. fragilis genome control variable gene expression. Science 307 (2005) 1463-1465
91. Patrick S., Parkhill J., McCoy L.J., Lennard N., Larkin M.J., Collins M., et al. Multiple inverted DNA repeats of Bacteroides fragilis that control polysaccharide antigenic variation are similar to the hin region inverted repeats of Salmonella typhimurium. Microbiology 149 (2003) 915-924
92. Xu J., Chiang H.C., Bjursell M.K., and Gordon J.I. Message from a human gut symbiont: sensitivity is a prerequisite for sharing. Trends Microbiol 12 (2004) 21-28
93. Stock A.M., Robinson V.L., and Goudreau P.N. Two-component signal transduction. Annu Rev Biochem 69 (2000) 183-215
94. Corzo G., and Gilliland S.E. Measurement of bile salt hydrolase activity from Lactobacillus acidophilus based on disappearance of conjugated bile salts. J Dairy Sci 82 (1999) 466-471
95. Stellwag E.J., and Hylemon P.B. Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis. Biochim Biophys Acta 452 (1976) 165-176
96. Begley M., Gahan C.G., and Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 29 (2005) 625-651
97. Bron P.A., Marco M., Hoffer S.M., Van M.E., de Vos W.M., and Kleerebezem M. Genetic characterization of the bile salt response in Lactobacillus plantarum and analysis of responsive promoters in vitro and in situ in the gastrointestinal tract. J Bacteriol 186 (2004) 7829-7835
98. De B.P., and Verstraete W. Bile salt deconjugation by lactobacillus plantarum 80 and its implication for bacterial toxicity. J Appl Microbiol 87 (1999) 345-352
99. Pumbwe L., Chang A., Smith R.L., and Wexler H.M. Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates. J Antimicrob Chemother 58 (2006) 543-548